proposed that CD8 T cell recognition of tumor-associated antigens (TAA) to kill tumor cells is a key aspect of the antitumor effect in HCC and that these responses are more robust in early HCC (69). This evidence concerns the gene CD8A and hepatocellular carcinoma.